Steps Targets

Daily step count is a simple, trackable proxy for overall daily movement (much of it NEAT, see NEAT & Daily Movement) and a strong correlate of health.

Verified/updated 2026-09-01: the best current evidence is Ding et al., a systematic review and dose-response meta-analysis covering 160,000+ people across studies published 2014-2025 (Lancet Public Health 2025;10(8):e668-81) — larger and more current than the previously-cited Paluch et al. 2022 meta-analysis (still real and corroborating, 15 cohorts, 47,471 adults). Ding et al.'s headline numbers, at ~7,000 steps/day vs. a low-step baseline: 47% lower all-cause mortality risk, 25% lower cardiovascular disease incidence, 47% lower cardiovascular mortality, 37% lower cancer mortality, 14% lower type 2 diabetes risk. Critically, 10,000 steps/day offers only trivial incremental benefit over 7,000 — all-cause mortality risk reduction is 48% at 10,000 vs. 47% at 7,000, and for several outcomes (diabetes, cancer incidence, falls) there's no statistically significant advantage of 10,000 over 7,000 at all. Meaningful benefit already appears by ~4,000 steps/day.

• More steps → progressively lower all-cause mortality, with the lowest risk around ~7,000–9,000 steps/day in the overall sample (Paluch et al. 2022, corroborated by Ding et al. 2025's ~7,000 finding above).
• The benefit plateaus by age: ~6,000–8,000 steps/day for adults ≥60, and ~8,000–10,000 steps/day for adults <60 (Paluch et al. 2022).
• Steps below the plateau still matter most — the steepest risk reduction happens going from very low (e.g., ~2,000–4,000) toward moderate counts. The biggest wins are for the least active.
• "10,000 steps" is a marketing figure (from a 1960s Japanese pedometer named manpo-kei, "10,000-steps meter"), not an evidence-based requirement. Real benefit appears well below it, and the 2025 meta-analysis now quantifies just how small the 7,000-vs-10,000 gap actually is (above).
• Pace/intensity: mixed evidence, resolved 2026-09-01. A UK Biobank cohort study (~78,500 adults) found stepping cadence (peak-30 cadence specifically) associated with lower mortality/morbidity risk beyond total step volume alone. However, a separate NHANES cross-sectional analysis found step intensity was not significantly associated with lower mortality after adjusting for age, BMI, and self-rated health — those factors may confound the raw intensity-mortality association. Net: total step volume is the well-established, simpler lever; an added intensity benefit is plausible and seen in at least one large cohort, but isn't as settled as the volume finding, so don't overstate it.

Practical use:

• Establish your baseline, then aim to add ~1,000–2,000 steps/day over it as a first goal — incremental beats an intimidating fixed number.
• Steps complement, don't replace, the structured activity guidelines (moderate/vigorous aerobic + strength, see Cardiorespiratory Conditioning Guidelines (Peterson & Bryant / ACSM)).
• Wearables make tracking easy (see Wearable Accuracy and Its Limits, What to Log for Strength Training); brisk walking is the main vehicle (see Walking (Cardio Modality)).

• Lowest mortality ~7,000–9,000 steps/day overall.
• Plateau: ~6,000–8,000 (age ≥60); ~8,000–10,000 (age <60).
• Biggest gains come from raising very-low counts; "10,000 steps" is marketing, not science.
• Aim to add ~1,000–2,000/day over your baseline; steps complement the activity guidelines.